Nelarabine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nelarabine. Educational only — not medical advice.
Labeled uses
Nelarabine Injection is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.
Source: FDA labeling via NIH DailyMed (set 21919314…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.